Sionna Therapeutics, Inc. · NASDAQ:SION

Orbimed Advisors LLC sold 292,952 Sionna Therapeutics, Inc. shares (Form 4)

Traded May 7 to May 11, 2026 · Filed May 11, 2026

From May 7 to May 11, 2026, Orbimed Advisors LLC (Director) sold 292,952 Sionna Therapeutics, Inc. shares at an average US$45.62 for US$13.4M under a trading plan, leaving 2,671,822 shares. Filed May 11, 2026 (Form 4).

Sold
292,952 shares
Price
US$45.62 average (US$44.58 to US$46.22)
Value
US$13.4M
Holding after
2,671,822 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 7, 2026Common StockSale48,546US$44.612,916,228Indirect
May 8, 2026Common StockSale59,767US$44.582,856,461Indirect
May 11, 2026Common StockSale184,639US$46.222,671,822Indirect

Source

View original at SEC

Related